fluocinolone acetonide has been researched along with Skin Neoplasms in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (56.25) | 18.7374 |
| 1990's | 7 (21.88) | 18.2507 |
| 2000's | 4 (12.50) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdolkarimi, B; Aslani, FS; Karimi, M; Mokhtari, M; Sepaskhah, M | 1 |
| Karatsai, E; Robson, AG; Taylor, SRJ | 1 |
| Hori, Y; Iigo, M; Imai, T; Kitahashi, T; Sugimura, T; Takahashi, M; Takasuka, N; Wakabayashi, K; Yoshimi, N | 1 |
| Bossenbroek, NM; Johnson, H; Meehan, SA; Pomeranz, MK; Robles, M; Rosenman, K | 1 |
| Hanausek, M; Kinjo, T; Kowalczyk, M; Kowalczyk, P; Slaga, TJ; Walaszek, Z | 1 |
| Hanausek, M; Kinjo, T; Kowalczyk, M; Kowalczyk, P; Nishimaki, T; Slaga, TJ; Walaszek, Z | 1 |
| Adegboyega, P; Batra, V; Clifford, JL; Coburn, MA; DiGiovanni, J; Gill, JN; Kleiner-Hancock, HE; Mathis, JM; Shi, R; Syed, Z | 1 |
| Kalimi, GH; Sirsat, SM | 1 |
| Fischer, SM; Klein-Szanto, AJ; Major, S; Nelson, K; Slaga, TJ; Weeks, CE | 1 |
| Roenigk, HH | 1 |
| Fischer, SM; Klein-Szanto, AJ; Mamrack, M; Nelson, K; Slaga, TJ; Weeks, CE | 1 |
| Kim, TW; Smart, RC | 1 |
| Colburn, NH; Dong, Z; Lavrovsky, V | 1 |
| Albert, RE; French, JE; Maronpot, R; Spalding, J; Tennant, R | 1 |
| Bergfeld, WF; Brydon, JK; Newman, JM; Rindler, JM | 1 |
| Budunova, IV; Carbajal, S; Kang, H; Slaga, TJ; Viaje, A | 1 |
| Dawson, MI; Dong, Z; Flavell, RA; Huang, C; Ma, WY; Rincon, M | 1 |
| Holmgren, A; Kumar, S | 1 |
| Bracken, WM; Gleason, GL; Hennings, H; Slaga, TJ; Weeks, CE | 1 |
| Slaga, TJ; Thompson, S | 1 |
| Slaga, TJ; Viaje, A; Weinstein, IB; Wigler, M | 1 |
| Schwarz, JA; Slaga, TJ; Viaje, A | 1 |
| Roop, DR; Toftgard, R; Yuspa, SH | 1 |
| Hennings, H | 1 |
| Scribner, JD; Scribner, NK; Woodworth, BA | 1 |
| Marian, B | 1 |
| Chenicek, KJ; DiGiovanni, J; Kruszewski, FH | 1 |
| Fukao, K; Kayata, Y; Okuda, K; Takada, K; Tanimoto, Y; Yoshiga, K | 1 |
| Pence, BC; Reiners, JJ | 1 |
| Hennings, H; Yuspa, SH | 1 |
| Goldmann, L; Igelman, JM; Kitzmiller, K | 1 |
| Briggs, M; Briggs, MH | 1 |
1 review(s) available for fluocinolone acetonide and Skin Neoplasms
| Article | Year |
|---|---|
Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
Topics: Animals; Carcinogens; Cocarcinogenesis; Diterpenes; Epidermal Cells; Fluocinolone Acetonide; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Phorbol Esters; Polyamines; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin | 1982 |
31 other study(ies) available for fluocinolone acetonide and Skin Neoplasms
| Article | Year |
|---|---|
Hypo-pigmented mycosis fungoides is a rare malignancy in pediatrics.
Topics: Acitretin; Child; Fluocinolone Acetonide; Glucocorticoids; Humans; Hypopigmentation; Keratolytic Agents; Male; Mycosis Fungoides; Skin Neoplasms | 2018 |
Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Topics: Aged; Delayed-Action Preparations; Drug Implants; Electroretinography; Female; Fluocinolone Acetonide; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Immunosuppression Therapy; Intravitreal Injections; Melanoma; Paraneoplastic Syndromes, Ocular; Retinal Diseases; Skin Neoplasms; Tomography, Optical Coherence; Visual Acuity; Visual Fields | 2019 |
Promotion of mouse two-stage skin carcinogenesis by diacylglycerol-rich edible oil.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Diglycerides; Fatty Acids; Female; Fluocinolone Acetonide; Linoleic Acid; Mice; Oils; Oleic Acid; Protein Kinase C; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2009 |
Chronic cutaneous lupus erythematosus in vitiligo.
Topics: Autoimmunity; Carcinoma, Squamous Cell; Clobetasol; Diabetes Complications; Diagnostic Errors; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Middle Aged; Photosensitivity Disorders; Pruritus; Psoriasis; Skin Neoplasms; Sunlight; Ultraviolet Rays; Vitiligo | 2008 |
Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Interactions; Fluocinolone Acetonide; Glucocorticoids; Keratinocytes; Mice; Papilloma; Phosphodiesterase Inhibitors; Pyridines; Pyrimidinones; Rolipram; Skin; Skin Neoplasms; Time Factors | 2009 |
Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Blotting, Western; Carcinoma, Squamous Cell; Cell Nucleus; Cell Transformation, Neoplastic; Cytoplasm; Desipramine; Fluocinolone Acetonide; Keratinocytes; Luciferases; Metallothionein; Mice; Papilloma; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Transcription, Genetic | 2009 |
Effects of the tropical ginger compound,1'-acetoxychavicol acetate, against tumor promotion in K5.Stat3C transgenic mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alpinia; Animals; Benzyl Alcohols; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Fluocinolone Acetonide; Humans; Mice; Mice, Transgenic; NF-kappa B; Plant Extracts; Skin Neoplasms; STAT3 Transcription Factor; Tetradecanoylphorbol Acetate; Zingiber officinale | 2012 |
The relevance of gap junctions to stage I tumor promotion in mouse epidermis.
Topics: Animals; Cell Communication; Diterpenes; Dose-Response Relationship, Drug; Female; Fluocinolone Acetonide; Intercellular Junctions; Mice; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin | 1984 |
Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Diterpenes; Epidermal Cells; Female; Fluocinolone Acetonide; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Phorbol Esters; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin | 1980 |
[Modern therapy of mycosis fungoides].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Mechlorethamine; Mycosis Fungoides; Neoplasm Staging; PUVA Therapy; Radiotherapy Dosage; Skin Neoplasms | 1983 |
Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Base Sequence; Carcinogens; Cell Division; Drug Interactions; Ear, External; Edema; Female; Fluocinolone Acetonide; Genes, ras; Genotype; Mice; Mice, Inbred Strains; Mirex; Molecular Sequence Data; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin | 1995 |
Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors.
Topics: Animals; Anticarcinogenic Agents; Cell Transformation, Neoplastic; Cells, Cultured; Colforsin; Cyclic AMP; Drug Resistance; Fluocinolone Acetonide; Glucocorticoids; Mice; Phenotype; Sensitivity and Specificity; Skin; Skin Neoplasms; Time Factors; Transcription Factor AP-1; Transcriptional Activation; Tretinoin | 1995 |
Mechanism of skin tumorigenesis by contact sensitizers: the effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4 dinitro-1-fluorobenzene in the skin of the TG.AC (v-Ha-ras) mouse.
Topics: Animals; Dermatitis, Contact; Dinitrofluorobenzene; Dose-Response Relationship, Drug; Female; Fluocinolone Acetonide; Genes, ras; Glucocorticoids; Mice; Mice, Transgenic; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1996 |
Stevens-Johnson syndrome associated with topical nitrogen mustard therapy.
Topics: Administration, Cutaneous; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Mechlorethamine; Mycosis Fungoides; Neoplasm Recurrence, Local; Ointments; PUVA Therapy; Skin Neoplasms; Stevens-Johnson Syndrome | 1997 |
Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Fluocinolone Acetonide; Hyperplasia; Keratinocytes; Mice; Mice, Inbred Strains; Papilloma; Receptors, Glucocorticoid; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factors | 1997 |
Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Female; Fluocinolone Acetonide; Luciferases; Male; Mice; Mice, Transgenic; Papilloma; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Retinoids; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcriptional Activation; Tretinoin | 1997 |
Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Calcimycin; Calcium; Carcinogens; Cocarcinogenesis; Diglycerides; Diterpenes; Enzyme Activation; Enzyme Induction; Epidermis; Female; Fluocinolone Acetonide; Gene Expression Regulation; Glutaredoxins; Glutathione; Ionophores; Mice; Oxidation-Reduction; Oxidoreductases; Phorbol Esters; Protein Kinase C; Proteins; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Thioredoxin-Disulfide Reductase; Thioredoxins; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin | 1999 |
Inhibition of phorbol ester-induced tumor promotion in mice by vitamin A analog and anti-inflammatory steroid.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cocarcinogenesis; Drug Synergism; Female; Fluocinolone Acetonide; Mice; Neoplasms, Experimental; Papilloma; Phorbols; Skin Neoplasms; Tetradecanoylphorbol Acetate; Vitamin A | 1979 |
The effects of dexamethasone on mouse skin initiation and aryl hydrocarbon hydroxylase.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Aryl Hydrocarbon Hydroxylases; Benz(a)Anthracenes; Dexamethasone; Estradiol; Female; Flavonoids; Fluocinolone Acetonide; Mice; Neoplasms, Experimental; Papilloma; Pregnadienetriols; Skin Neoplasms; Testosterone | 1976 |
Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator.
Topics: Animals; Anti-Inflammatory Agents; Cell Division; Cells, Cultured; Depression, Chemical; DNA; Female; Fluocinolone Acetonide; Fluocinonide; Mice; Neoplasms, Experimental; Phorbol Esters; Phorbols; Plasminogen Activators; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1977 |
Fluocinolone acetonide: a potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis.
Topics: Animals; DNA; Female; Fluocinolone Acetonide; Kinetics; Mice; Neoplasms, Experimental; Papilloma; Phorbol Esters; Skin; Skin Neoplasms; Thymidine; Time Factors | 1977 |
Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate.
Topics: Animals; Carcinoma; Female; Fluocinolone Acetonide; Gene Expression Regulation; Keratins; Mice; Molecular Weight; Papilloma; Phorbols; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1985 |
Malignant conversion: the first stage in progression from benign to malignant tumors.
Topics: Animals; Carcinoma; Cell Transformation, Neoplastic; Fluocinolone Acetonide; Mice; Papilloma; Skin Neoplasms | 1989 |
Enhancement of beta-propiolactone tumorigenesis in mouse skin by pretreatment with the anti-inflammatory steroid fluocinolone acetonide.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Drug Synergism; Female; Fluocinolone Acetonide; Lactones; Mice; Mice, Inbred Strains; Propiolactone; Skin Neoplasms | 1986 |
Tumor-promoting phorbol esters cause a stable reduction of dermal collagen in mouse skin.
Topics: Animals; Calcimycin; Cell Division; Collagen; Female; Fluocinolone Acetonide; Mice; Phorbol Esters; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin | 1987 |
Modulation of chrysarobin skin tumor promotion.
Topics: Animals; Anthracenes; Carcinogens; Cocarcinogenesis; Eflornithine; Female; Fluocinolone Acetonide; Mice; Ornithine Decarboxylase; Papilloma; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin | 1988 |
Effects of fluocinolone acetonide on mouse skin sterol metabolism and two-stage carcinogenesis.
Topics: Animals; Chromatography, Gas; Dose-Response Relationship, Drug; Fluocinolone Acetonide; Methylcholanthrene; Mice; Skin; Skin Neoplasms; Sterols; Tetradecanoylphorbol Acetate | 1988 |
Murine epidermal xanthine oxidase activity: correlation with degree of hyperplasia induced by tumor promoters.
Topics: Animals; Carcinogens; Epidermis; Female; Fluocinolone Acetonide; Mice; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin; Xanthine Oxidase | 1987 |
Two-stage tumor promotion in mouse skin: an alternative interpretation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cocarcinogenesis; Croton Oil; Fluocinolone Acetonide; Mice; Mice, Inbred Strains; Papilloma; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tosylphenylalanyl Chloromethyl Ketone; Tretinoin | 1985 |
Investigative studies with DMSO in dermatology.
Topics: Animals; Dermatomycoses; Dimethyl Sulfoxide; Drug Eruptions; Fluocinolone Acetonide; Fluorouracil; Guinea Pigs; Humans; Pharmaceutical Vehicles; Pigmentation Disorders; Radiation Injuries, Experimental; Radiation-Protective Agents; Skin Absorption; Skin Diseases; Skin Neoplasms; Tissue Preservation | 1967 |
Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Benz(a)Anthracenes; Benzopyrenes; Betamethasone; Carcinogens; Dimethyl Sulfoxide; Enzyme Induction; Flavonoids; Fluocinolone Acetonide; Glucocorticoids; Hydrocarbons; Injections, Intraperitoneal; Male; Methylcholanthrene; Mice; Mixed Function Oxygenases; Neoplasms, Experimental; Pregnanetriol; Skin; Skin Neoplasms | 1973 |